Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Bourgeois, Valentin
94  Ergebnisse:
Personensuche X
?
1

OMIXCARE: OMICS technologies solved about 33% of the patien..:

Colin, Estelle ; Duffourd, Yannis ; Tisserant, Emilie...
Frontiers in Cell and Developmental Biology.  10 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
2

Epileptic encephalopathy as a new feature of the sudden inf..:

Mazel, Benoit ; Mallet, Delphine ; Roucher‐Boulez, Florence...
American Journal of Medical Genetics Part A.  188 (2022)  12 - p. 3540-3545 , 2022
Link: https://doi.org/10.1002/..
 
?
3

Interest of exome sequencing trio‐like strategy based on po..:

Tran Mau‐Them, Frederic ; Duffourd, Yannis ; Vitobello, Antonio...
Molecular Genetics & Genomic Medicine.  9 (2021)  12 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
4

Diagnosis of exon 12‐positive polycythemia vera rescued by ..:

Geay, Antoine ; Aral, Bernard ; Bourgeois, Valentin...
Clinical Case Reports.  8 (2020)  5 - p. 790-792 , 2020
Link: https://doi.org/10.1002/..
 
?
5

Impact of interferon on a triple positive polycythemia vera:

Campario, Hugo ; Mosca, Matthieu ; Aral, Bernard...
Leukemia.  34 (2019)  4 - p. 1210-1212 , 2019
Link: https://doi.org/10.1038/..
 
?
6

High HFE mutation incidence in idiopathic erythrocytosis:

Burlet, Bénédicte ; Bourgeois, Valentin ; Buriller, Céline...
British Journal of Haematology.  185 (2018)  4 - p. 794-795 , 2018
Link: https://doi.org/10.1111/..
 
?
7

OMIXCARE: OMICS technologies solved about 33% of the patien..:

Colin, Estelle ; Duffourd, Yannis ; Tisserant, Emilie...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fcell.2022.1021785.  , 2022
Link: https://univ-rennes.hal...
 
?
8

OMIXCARE: OMICS technologies solved about 33% of the patien..:

Colin, Estelle ; Duffourd, Yannis ; Tisserant, Emilie...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fcell.2022.1021785.  , 2022
Link: https://univ-rennes.hal...
 
?
9

OMIXCARE: OMICS technologies solved about 33% of the patien..:

Colin, Estelle ; Duffourd, Yannis ; Tisserant, Emilie...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fcell.2022.1021785.  , 2022
Link: https://univ-rennes.hal...
 
?
10

OMIXCARE: OMICS technologies solved about 33% of the patien..:

Colin, Estelle ; Duffourd, Yannis ; Tisserant, Emilie...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fcell.2022.1021785.  , 2022
Link: https://univ-rennes.hal...
 
?
11

OMIXCARE: OMICS technologies solved about 33% of the patien..:

Colin, Estelle ; Duffourd, Yannis ; Tisserant, Emilie...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fcell.2022.1021785.  , 2022
Link: https://univ-rennes.hal...
 
?
12

OMIXCARE: OMICS technologies solved about 33% of the patien..:

Colin, Estelle ; Duffourd, Yannis ; Tisserant, Emilie...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fcell.2022.1021785.  , 2022
Link: https://univ-rennes.hal...
 
?
13

OMIXCARE: OMICS technologies solved about 33% of the patien..:

Colin, Estelle ; Duffourd, Yannis ; Tisserant, Emilie...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fcell.2022.1021785.  , 2022
Link: https://univ-rennes.hal...
 
?
14

OMIXCARE: OMICS technologies solved about 33% of the patien..:

Colin, Estelle ; Duffourd, Yannis ; Tisserant, Emilie...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fcell.2022.1021785.  , 2022
Link: https://univ-rennes.hal...
 
?
15

OMIXCARE: OMICS technologies solved about 33% of the patien..:

Colin, Estelle ; Duffourd, Yannis ; Tisserant, Emilie...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fcell.2022.1021785.  , 2022
Link: https://univ-rennes.hal...
 
1-15